Cargando…
The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease
Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation and progressive fibrosis, typically affecting the skin, with variable internal organ involvement. Interstitial lung disease (ILD), with a prevalence between 35 and 75%, is the leading cause of d...
Autores principales: | Martín-López, María, Carreira, Patricia E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607647/ https://www.ncbi.nlm.nih.gov/pubmed/37892818 http://dx.doi.org/10.3390/jcm12206680 |
Ejemplares similares
-
Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022) -
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022) -
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021) -
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
por: Zheng, Boyang, et al.
Publicado: (2023) -
Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
por: Ozmen, Mustafa, et al.
Publicado: (2023)